Piera Angelica Merlini

Author

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Also Known As

David Altshuler, Mario Marzilli, Merlini, Piera A, Nora Franceschini, P A Merlini, P Ameri, P MERLINI, P Merlini, P Sormani, P. A. Merlini

136

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda Istituti di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Fondazione University of Milan University of Pavia

About

Piera Angelica Merlini is an author at Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	28	3.2K
2	Public Health	9	9	833
3	Health Sciences	3	3	130
4	Biostatistics	1	1	347
5	Diabetes	1	1	33

Piera Angelica Merlini

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia Amit V. Khera, Hong‐Hee Won, Gina M. Peloso, Journal of the American College of Cardiology Lipid DisorderClinical UtilityGeneticsMedicinePathology	2016	896
Association of Low-Frequency and Rare Coding-Sequence Variants with Blood Lipids and Coronary Heart Disease in 56,000 Whites and Blacks Gina M. Peloso, Paul L. Auer, Joshua C. Bis, The American Journal of Human Genetics Genome-wide Association StudyAllelic VariantEpidemiologyCardiovascular EpidemiologyCardiovascular Disease	2014	347
Sirolimus-Eluting vs Uncoated Stents for Prevention of Restenosis in Small Coronary Arteries Diego Ardissino, Claudio Cavallini, Ezio Bramucci, JAMA	2004	315
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels Connor A. Emdin, Amit Khera, Pradeep Natarajan, Journal of the American College of Cardiology GeneticsGenetic EpidemiologyPhenotypic CharacterizationLipoprotein MetabolismMedicine	2016	247
Tissue-factor antigen and activity in human coronary atherosclerotic plaques Diego Ardissino, Piera Angelica Merlini, Robert A.S. Ariëns, The Lancet InflammationVascular DiseaseCardiovascular DiseaseImmunologyPathology	1997	228
Prothrombotic Genetic Risk Factors in Young Survivors of Myocardial Infarction Diego Ardissino, Pier Mannuccio Mannucci, Piera Angelica Merlini, Blood	1999	224
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial Benjamin M. Scirica, Marc P. Bonaca, Eugene Braunwald, The Lancet ThrombosisCardiovascular DiseaseTra 2°P-timi 50MedicineSecondary Prevention	2012	212
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Journal of the American Heart Association	2016	196
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease Amit V. Khera, Hong‐Hee Won, Gina M. Peloso, JAMA	2017	196
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes Francesca M. Notarangelo, Giuseppe Maglietta, P Bevilacqua, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseBlood PlateletAtherosclerosisSelecting Antiplatelet Therapy	2018	188

Page 1